Published in Sex Health on May 01, 2006
Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis (2010) 3.79
Disparities among US states in HIV-related mortality in persons with HIV infection, 2001-2007. AIDS (2012) 1.27
AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS (2009) 1.17
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc (2010) 0.94
Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis (2009) 0.93
Determinants of suicide and accidental or violent death in the Australian HIV Observational Database. PLoS One (2014) 0.90
Early diagnosis and treatment of HIV infection: magnitude of benefit on short-term mortality is greatest in older adults. Age Ageing (2013) 0.83
Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis. PLoS One (2013) 0.81
Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections. Sex Health (2011) 0.78
Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med (2007) 12.93
Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21
Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet (2006) 4.45
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care (2008) 4.10
The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr (2005) 3.18
Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis (2009) 2.89
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil (2010) 2.70
HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis (2011) 2.08
Rates of combination antiretroviral treatment change in Australia, 1997-2000. HIV Med (2002) 2.02
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis (2012) 2.01
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98
The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol (2003) 1.78
Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health (2009) 1.70
Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis. AIDS (2014) 1.59
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med (2003) 1.52
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS (2007) 1.49
Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol (2006) 1.45
Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust (2003) 1.41
Suicide risk among recently released prisoners in New South Wales, Australia. Med J Aust (2007) 1.28
An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int (2008) 1.23
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS (2010) 1.23
Factors associated with mortality in a cohort of Australian prisoners. Eur J Epidemiol (2007) 1.18
AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS (2009) 1.17
Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr (2009) 1.16
Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther (2005) 1.14
Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy. PLoS One (2012) 1.14
The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database. J Clin Virol (2003) 1.13
Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS (2012) 1.11
Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood. PLoS Pathog (2008) 1.10
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. AIDS (2011) 1.08
The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. J Acquir Immune Defic Syndr (2009) 1.04
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. J Int AIDS Soc (2012) 1.03
Modeling trends in HIV incidence among homosexual men in Australia 1995-2006. J Acquir Immune Defic Syndr (2004) 1.00
Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infect Dis (2010) 0.97
HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting. AIDS (2005) 0.97
Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009. J Acquir Immune Defic Syndr (2014) 0.96
The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies. AIDS (2009) 0.95
Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD. AIDS Res Treat (2012) 0.95
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc (2010) 0.94
Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype. AIDS (2010) 0.94
Hospitalizations in a cohort of HIV patients in Australia, 1999-2007. AIDS (2010) 0.93
Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. J Gastroenterol Hepatol (2011) 0.93
Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD). HIV Med (2012) 0.93
Epidemiology of hepatitis C virus infection in Australia. Aust Fam Physician (2003) 0.92
Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia. Sex Health (2007) 0.92
Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression. J Acquir Immune Defic Syndr (2009) 0.92
The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol (2009) 0.92
Rapidly ageing HIV epidemic among men who have sex with men in Australia. Sex Health (2009) 0.91
Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database. J Int AIDS Soc (2012) 0.90
The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol (2003) 0.90
Determinants of suicide and accidental or violent death in the Australian HIV Observational Database. PLoS One (2014) 0.90
Loss to follow-up in the Australian HIV Observational Database. Antivir Ther (2014) 0.89
The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence. Sex Health (2013) 0.89
Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression. AIDS Res Hum Retroviruses (2009) 0.87
CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts. J Acquir Immune Defic Syndr (2011) 0.87
Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Med J Aust (2011) 0.87
Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast Asia. PLoS One (2010) 0.87
STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia. BMC Infect Dis (2013) 0.85
Modelling HIV incidence in gay men: increased treatment, unsafe sex and sexually transmissible infections. AIDS (2002) 0.85
Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol (2010) 0.84
A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: the CREST study. PLoS Clin Trials (2006) 0.84
Hepatitis C treatment outcomes in Australian clinics. Med J Aust (2012) 0.84
Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections. Sex Health (2008) 0.84
Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database. HIV Med (2005) 0.83
Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Sex Transm Dis (2013) 0.83
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals. AIDS (2012) 0.82
Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol (2007) 0.82
Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-infected patients. J AIDS Clin Res (2010) 0.82
Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals. Curr Opin HIV AIDS (2014) 0.82
High viral fitness during acute HIV-1 infection. PLoS One (2010) 0.82
Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection. Vaccine (2013) 0.81
Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study. BMC Public Health (2011) 0.80
Recent trends in early stage response to combination antiretroviral therapy in Australia. Antivir Ther (2014) 0.79
Population movement can sustain STI prevalence in remote Australian indigenous communities. BMC Infect Dis (2013) 0.79
The impact of wild-type reversion on transmitted resistance surveillance. Antivir Ther (2014) 0.78
Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion--the Health in Men (HIM) Biomarker Substudy. Antivir Ther (2012) 0.78
Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia. J Gastroenterol Hepatol (2008) 0.78
Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc (2015) 0.78
Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons. Curr Opin HIV AIDS (2016) 0.78
Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia. J Hepatol (2010) 0.77
Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD. J Acquir Immune Defic Syndr (2011) 0.75
Causes of death in hepatitis B and C: a methodological issue. Lancet (2007) 0.75
Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD). BMC Infect Dis (2015) 0.75
Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men. J Acquir Immune Defic Syndr (2016) 0.75
The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental models. BMC Infect Dis (2013) 0.75
Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013. J Acquir Immune Defic Syndr (2017) 0.75
A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort. J Acquir Immune Defic Syndr (2014) 0.75
Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific Region. J Antivir Antiretrovir (2009) 0.75
HIV and Aging: Demographic Change in the Asia-Pacific Region. J Acquir Immune Defic Syndr (2017) 0.75
Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study. J Acquir Immune Defic Syndr (2014) 0.75